This evidence suggested that VEGF and the NF-κB signaling pathway are involved in rBmK AGAP inhibition of breast xenograft tumor growth and corroborated with the earlier observation made from the IVIM-MRI analysis of antiproliferation effects of BmK AGAP. Here, NFKB1 is linked to medical procedure.